Literature DB >> 17564651

Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer.

Polina Voronov1, Henry J Przybylo, Narasimhan Jagannathan.   

Abstract

We present a case of a 29 months old previously healthy child who experienced apnea resulting in brain injury following a dose of acetaminophen and codeine 2 days after an uneventful anesthetic for tonsillectomy. A genetic polymorphism leading to ultra-rapid metabolism of codeine into morphine resulted in narcosis and apnea. This paper discusses the use of codeine for pain relief, obstructive sleep apnea, the alteration of the CYP2D6 gene and the resulting effect on drug metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17564651     DOI: 10.1111/j.1460-9592.2006.02182.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  27 in total

1.  Has the time come to phase out codeine?

Authors:  Noni MacDonald; Stuart M MacLeod
Journal:  CMAJ       Date:  2010-10-04       Impact factor: 8.262

2.  Pharmacogenetic testing: Current Evidence of Clinical Utility.

Authors:  Jivan Moaddeb; Susanne B Haga
Journal:  Ther Adv Drug Saf       Date:  2013-08-01

3.  Pain after tonsillectomy: effectiveness of current guidelines?

Authors:  Y Walrave; C Maschi; S Bailleux; A T Falk; C Hayem; M Carles; F De la Brière
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-10-27       Impact factor: 2.503

Review 4.  Value of Supportive Care Pharmacogenomics in Oncology Practice.

Authors:  Jai N Patel; Lauren A Wiebe; Henry M Dunnenberger; Howard L McLeod
Journal:  Oncologist       Date:  2018-04-05

Review 5.  Drugs for chronic pain in children: a commentary on clinical practice and the absence of evidence.

Authors:  Marie-Claude Grégoire; G Allen Finley
Journal:  Pain Res Manag       Date:  2013 Jan-Feb       Impact factor: 3.037

6.  Oral administration of morphine versus ibuprofen to manage postfracture pain in children: a randomized trial.

Authors:  Naveen Poonai; Gina Bhullar; Kangrui Lin; Adam Papini; David Mainprize; Jocelyn Howard; John Teefy; Michelle Bale; Cindy Langford; Rodrick Lim; Larry Stitt; Michael J Rieder; Samina Ali
Journal:  CMAJ       Date:  2014-10-27       Impact factor: 8.262

Review 7.  Genetic variability of pain perception and treatment--clinical pharmacological implications.

Authors:  Jörn Lötsch
Journal:  Eur J Clin Pharmacol       Date:  2011-02-23       Impact factor: 2.953

Review 8.  Human cytochromes P450 in health and disease.

Authors:  Daniel W Nebert; Kjell Wikvall; Walter L Miller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-06       Impact factor: 6.237

Review 9.  Opioid use and the risk of respiratory depression and death in the pediatric population.

Authors:  Marianne R Whittaker
Journal:  J Pediatr Pharmacol Ther       Date:  2013-10

10.  Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomy.

Authors:  Jacek Biesiada; Vidya Chidambaran; Michael Wagner; Xue Zhang; Lisa J Martin; Jaroslaw Meller; Senthilkumar Sadhasivam
Journal:  Pharmacogenomics       Date:  2014-11       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.